Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis

Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis

IntroductionNo prior meta-analysis has investigated the impact of programmed cell death protein 1 (PD-1) inhibitor therapy on survival outcomes in patients with advanced or recurrent uterine cancers (including both corpus and cervical cancers).MethodsA comprehensive search of PubMed and Embase datab...

Full description

Bibliographic Details
Main Authors: Keng-Wei Liang, Liang-Jou Chen, Chun-Hao Wang, Kevin Sheng-Kai Ma, Li-Hsin Hsia, Po-Hui Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
uterine cancer
PD-1 inhibitors
survival
adverse events
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1331994/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1331994/full

Similar Items